GlassScriptPhysician profile
Kenneth Tieu
NPI 1902122781
$29,785.95
in general payments reported to CMS, 2019-2025
15 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $13K · 2021: $5,452 · 2022: $411 · 2023: $8,827 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,190 · Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,190.00 |
| Food and Beverage | $822.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $13,316.88 | 2019-2020 | |
| Depuy Synthes Sales INC. | $8,580.00 | 2021-2023 | |
| Ethicon US, LLC | $3,984.34 | 2019-2023 | Echelon Flex, Echelon Endopath |
| Intuitive Surgical, INC. | $2,139.69 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $721.71 | 2019-2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Medtronic, INC. | $573.34 | 2022-2025 | Signia |
| Kvk-Tech, INC. | $99.17 | 2020-2021 | |
| Covidien LP | $89.80 | 2019 | |
| Endo Pharmaceuticals INC. | $89.48 | 2019-2021 | |
| Novo Nordisk INC | $87.31 | 2019-2023 | Wegovy |
| Smith+Nephew, INC. | $30.02 | 2023 | Renasys Go V2 Home, Pico, Pico 14 |
| Nalpropion Pharmaceuticals LLC | $21.92 | 2019 | |
| Shire North American Group INC | $21.44 | 2019 | |
| Daiichi Sankyo INC. | $15.69 | 2019 | |
| Vivus LLC | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Tieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.